Evidence map›Paper›PMID 25183325›Full record

ReviewAsian Pacific journal of tropical biomedicine2014

An overview of travel-associated central nervous system infectious diseases: risk assessment, general considerations and future directions.

Morteza Izadi, Arman Is'haqi, Mohammad Ali Is'haqi, Nematollah Jonaidi Jafari, Fatemeh Rahamaty, Abdolali Banki

Open access · diamondAbstract readReview
In one paragraph

Review in Asian Pacific journal of tropical biomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Morteza IzadiBaqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Arman Is'haqiDepartment of Neurology, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali Is'haqiDepartment of Infectious Diseases, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran Iran.
Nematollah Jonaidi JafariBaqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Fatemeh RahamatyBaqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abdolali BankiDepartment of Neurology, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Baqiyatallah University of Medical Sciences · IRIran University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nervous system infections are among the most important diseases in travellers. Healthy travellers might be exposed to infectious agents of central nervous system, which may require in-patient care. Progressive course is not uncommon in this family of disorders and requires swift diagnosis. An overview of the available evidence in the field is, therefore, urgent to pave the way to increase the awareness of travel-medicine practitioners and highlights dark areas for future research. In November 2013, data were collected from PubMed, Scopus, and Web of Knowledge (1980 to 2013) including books, reviews, and peer-reviewed literature. Works pertained to pre-travel care, interventions, vaccinations related neurological infections were retrieved. Here we provide information on pre-travel care, vaccination, chronic nervous system disorders, and post-travel complications. Recommendations with regard to knowledge gaps, and state-of-the-art research are made. Given an increasing number of international travellers, novel dynamic ways are available for physicians to monitor spread of central nervous system infections. Newer research has made great progresses in developing newer medications, detecting the spread of infections and the public awareness. Despite an ongoing scientific discussion in the field of travel medicine, further research is required for vaccine development, state-of-the-art laboratory tests, and genetic engineering of vectors.

Indexed as

Infectious diseasesNervous system disordersTravel medicine

Identifiers

PMID25183325
PMCPMC4037649
OpenAlexW2055091077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.